[1]
M. K. Abdulridha, “POTENTIAL MODULATION OF DISEASE ACTIVITY INDICES AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH ACTIVE INFLAMMATORY BOWEL DISEASE ON MELATONIN ADJUVANT THERAPY”, Asian J Pharm Clin Res, vol. 11, no. 6, pp. 476–481, Jun. 2018.